Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 846531, 5 pages
http://dx.doi.org/10.1155/2014/846531
Research Article

The Diagnostic Value of β-Human Chorionic Gonadotropin, Progesterone, and Ischemia-Modified Albumin and Their Combined Use in the Prediction of First Trimester Abortions

1Department of Obstetrics and Gynecology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey
2Department of Biochemistry, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey

Received 9 April 2014; Accepted 5 June 2014; Published 1 July 2014

Academic Editor: Christos Iavazzo

Copyright © 2014 Mehmet A. Osmanağaoğlu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. B. van Rijn, A. Franx, J. M. Sikkema, H. J. M. van Rijn, H. W. Bruinse, and H. A. M. Voorbij, “Ischemia modified albumin in normal pregnancy and preeclampsia,” Hypertension in Pregnancy, vol. 27, no. 2, pp. 159–167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Guven, A. Alver, A. Menteşe, F. C. İlhan, M. Çalapoğlu, and M. A. Unsal, “The novel ischemia marker “ischemia-modified albumin” is increased in normal pregnancies,” Acta Obstetricia et Gynecologica Scandinavica, vol. 88, no. 4, pp. 479–482, 2009. View at Publisher · View at Google Scholar
  3. Y. Üstün, Y. Engin-Üstün, O. Öztürk, I. Alanbay, and H. Yaman, “Ischemia-modified albumin as an oxidative stress marker in preeclampsia,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 24, pp. 418–421, 2011. View at Google Scholar
  4. C. A. Hubel, “Oxidative stress in the pathogenesis of preeclampsia,” Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 3, pp. 222–235, 1999. View at Google Scholar · View at Scopus
  5. A. T. Papageorghiou, F. Prefumo, K. Leslie, D. C. Gaze, P. O. Collinson, and B. Thilaganathan, “Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin,” Human Reproduction, vol. 23, no. 4, pp. 803–806, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Iacovidou, D. D. Briana, M. Boutsikou et al., “Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies,” Mediators of Inflammation, vol. 2008, Article ID 523081, 5 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Özdemir, A. Kıyıcı, O. Balcı, H. Göktepe, H. Çiçekler, and Ç. Çelik, “Assessment of ischemia-modified albumin level in patients with recurrent pregnancy loss during the first trimester,” The European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 155, pp. 209–212, 2011. View at Google Scholar
  8. M. A. Osmanağaoğlu, İ. Erdoğan, S. Eminağaoğlu et al., “The diagnostic value of beta-human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions,” Journal of Obstetrics & Gynaecology, vol. 30, pp. 288–293, 2010. View at Publisher · View at Google Scholar
  9. D. Bar-Or, E. Lau, and J. V. Winkler, “A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report,” Journal of Emergency Medicine, vol. 19, no. 4, pp. 311–315, 2000. View at Publisher · View at Google Scholar
  10. P. L. Yudkin, M. Aboualfa, J. A. Eyre, C. W. G. Redman, and A. R. Wilkinson, “New birthweight and head circumference centiles for gestational ages 24 to 42 weeks,” Early Human Development, vol. 15, no. 1, pp. 45–52, 1987. View at Google Scholar · View at Scopus
  11. M. A. H. Al-Sebai, M. Diver, and L. J. Hipkin, “The role of a single free β-human chorionic gonadotrophin measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability,” Human Reproduction, vol. 11, no. 4, pp. 881–888, 1996. View at Google Scholar · View at Scopus
  12. J. de León, G. Sifuentes, C. Hopkins et al., “Maternal serum free β-hCG levels in uncomplicated pregnancies at the 10th–15th week of gestation and the development of obstetric complications,” The Journal of Reproductive Medicine, vol. 49, no. 2, pp. 89–92, 2004. View at Google Scholar · View at Scopus
  13. C. A. Daily, S. L. Laurent, and W. C. Nunley Jr., “The prognostic value of serum progesterone and quantitative β-human chorionic gonadotropin in early human pregnancy,” American Journal of Obstetrics and Gynecology, vol. 171, no. 2, pp. 380–384, 1994. View at Google Scholar · View at Scopus
  14. M. Hahlin, A. Wallin, P. Sjoblom, and B. Lindblom, “Single progesterone assay for early recognition of abnormal pregnancy,” Human Reproduction, vol. 5, no. 5, pp. 622–626, 1990. View at Google Scholar · View at Scopus
  15. S. Hjortshøj, S. R. Kristensen, and J. Ravkilde, “Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome,” American Journal of Emergency Medicine, vol. 28, no. 2, pp. 170–176, 2010. View at Publisher · View at Google Scholar · View at Scopus